SCHEMBL30860112

CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O

nearest known ligand 0.61

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	10/20	0.61

▸	ECE1	P42892	1/20	0.61

▸	MUS81	Q96NY9	1/20	0.61

▸	KEAP1	Q14145	1/20	0.60

▸	VIPR2	P41587	5/20	0.60

▸	VIPR1	P32241	3/20	0.60

▸	GCGR	P47871	1/20	0.60

▸	GIPR	P48546	1/20	0.60

▸	KISS1R	Q969F8	1/20	0.59

▸	GHSR	Q92847	2/20	0.57

▸	NPY2R	P49146	1/20	0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31065739	0.98	GLP1R (0.61)	GLP1RECE1MUS81KEAP1VIPR2
SCHEMBL31009219	0.98	GLP1R (0.61)	GLP1RECE1MUS81KEAP1VIPR2
SCHEMBL30763291	0.97	GLP1R (0.62)	GLP1RECE1MUS81KEAP1VIPR2
SCHEMBL31622726	0.97	GLP1R (0.62)	GLP1RECE1MUS81KEAP1VIPR2
SCHEMBL30860128	0.96	GLP1R (0.60)	GLP1RECE1MUS81KEAP1VIPR2
SCHEMBL30860116	0.96	GLP1R (0.60)	GLP1RECE1MUS81KEAP1VIPR2
SCHEMBL29894848	0.96	GLP1R (0.60)	GLP1RECE1MUS81VIPR2VIPR1
SCHEMBL31743242	0.95	GLP1R (0.61)	GLP1RECE1MUS81KEAP1VIPR2
SCHEMBL31053397	0.95	GLP1R (0.61)	GLP1RECE1MUS81VIPR2VIPR1
SCHEMBL31622727	0.95	GLP1R (0.61)	GLP1RECE1MUS81VIPR2VIPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-3856767-B1	FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES	ZEALAND PHARMA AS (DK)	2024-03-27	—	—	EP	disclosed